| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.63B | 37.06B | 37.38B | 39.23B | 34.57B | 33.90B |
| Gross Profit | 18.08B | 18.31B | 21.63B | 19.13B | 20.86B | 20.48B |
| EBITDA | 27.69B | 24.05B | 24.13B | 23.69B | 22.45B | 21.99B |
| Net Income | 18.36B | 15.15B | 15.86B | 16.01B | 15.30B | 14.84B |
Balance Sheet | ||||||
| Total Assets | 498.84B | 491.31B | 490.96B | 464.90B | 464.90B | 457.83B |
| Cash, Cash Equivalents and Short-Term Investments | 25.70B | 16.64B | 17.71B | 13.78B | 24.64B | 14.73B |
| Total Debt | 245.21B | 239.01B | 237.91B | 227.81B | 220.51B | 220.51B |
| Total Liabilities | 252.67B | 246.25B | 245.12B | 234.64B | 234.64B | 227.34B |
| Stockholders Equity | 246.17B | 245.06B | 245.84B | 230.78B | 230.25B | 230.49B |
Cash Flow | ||||||
| Free Cash Flow | 15.00B | 17.95B | -5.01B | 14.42B | 7.62B | 15.33B |
| Operating Cash Flow | 33.95B | 28.25B | 25.88B | 25.09B | 21.70B | 21.66B |
| Investing Cash Flow | -12.88B | -8.29B | -28.93B | -12.68B | -14.04B | -6.44B |
| Financing Cash Flow | -14.37B | -15.25B | 3.28B | -10.60B | -8.43B | -14.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ¥474.90B | 12.99 | 6.81% | 3.58% | 5.25% | 3.35% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥256.73B | 13.13 | ― | 3.47% | 13.25% | 3.76% | |
58 Neutral | ¥213.17B | 9.79 | 20.50% | 1.49% | 2.50% | -71.61% | |
58 Neutral | ¥340.10B | 53.14 | ― | 3.56% | 2.91% | 2.68% |